These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 3549727)
1. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. Stafforini DM; McIntyre TM; Carter ME; Prescott SM J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727 [TBL] [Abstract][Full Text] [Related]
3. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma. Stafforini DM; Carter ME; Zimmerman GA; McIntyre TM; Prescott SM Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2393-7. PubMed ID: 2928339 [TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095 [TBL] [Abstract][Full Text] [Related]
5. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415 [TBL] [Abstract][Full Text] [Related]
6. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. Tarbet EB; Stafforini DM; Elstad MR; Zimmerman GA; McIntyre TM; Prescott SM J Biol Chem; 1991 Sep; 266(25):16667-73. PubMed ID: 1653245 [TBL] [Abstract][Full Text] [Related]
7. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554 [TBL] [Abstract][Full Text] [Related]
8. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162 [TBL] [Abstract][Full Text] [Related]
9. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease). Pritchard PH; Chonn A; Yeung CC Blood; 1985 Dec; 66(6):1476-8. PubMed ID: 4063532 [TBL] [Abstract][Full Text] [Related]
10. PAF-acetylhydrolase, predominantly present in LDL in healthy subjects, is associated with HDL in a patient with LDL deficiency. Surya II; Mommersteeg M; Erkelens DW; Akkerman JW J Lipid Mediat; 1991; 3(1):27-38. PubMed ID: 1768838 [TBL] [Abstract][Full Text] [Related]
11. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum. Ostermann G; Kostner GM; Gries A; Malle E; Till U Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632 [TBL] [Abstract][Full Text] [Related]
12. Release of platelet-activating factor in systemic lupus erythematosus. Tetta C; Bussolino F; Modena V; Montrucchio G; Segoloni G; Pescarmona G; Camussi G Int Arch Allergy Appl Immunol; 1990; 91(3):244-56. PubMed ID: 2354868 [TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells. Satoh K; Imaizumi T; Yoshida H; Takamatsu S J Lab Clin Med; 1994 Feb; 123(2):225-31. PubMed ID: 8301198 [TBL] [Abstract][Full Text] [Related]
14. The degradation of platelet-activating factor by high-density lipoprotein in rat plasma. Effect of ethynyloestradiol administration. Pritchard PH Biochem J; 1987 Sep; 246(3):791-4. PubMed ID: 3689334 [TBL] [Abstract][Full Text] [Related]
15. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Imaizumi T; Satoh K; Yoshida H; Kawamura Y; Hiramoto M; Koyanagi M; Takamatsu S; Takamatsu M Heart Vessels; 1990; 5(2):81-6. PubMed ID: 2354992 [TBL] [Abstract][Full Text] [Related]
16. Determinants of plasma platelet-activating factor acetylhydrolase: heritability and relationship to plasma lipoproteins. Guerra R; Zhao B; Mooser V; Stafforini D; Johnston JM; Cohen JC J Lipid Res; 1997 Nov; 38(11):2281-8. PubMed ID: 9392426 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. Stafforini DM; Tjoelker LW; McCormick SP; Vaitkus D; McIntyre TM; Gray PW; Young SG; Prescott SM J Biol Chem; 1999 Mar; 274(11):7018-24. PubMed ID: 10066756 [TBL] [Abstract][Full Text] [Related]
18. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor. Suzuki Y; Miwa M; Harada M; Matsumoto M Eur J Biochem; 1988 Feb; 172(1):117-20. PubMed ID: 3345757 [TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme. Min JH; Wilder C; Aoki J; Arai H; Inoue K; Paul L; Gelb MH Biochemistry; 2001 Apr; 40(15):4539-49. PubMed ID: 11294621 [TBL] [Abstract][Full Text] [Related]
20. Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction. Stephens CJ; Graham RM; Sturm MJ; Richardson M; Taylor RR Coron Artery Dis; 1993 Feb; 4(2):187-93. PubMed ID: 8269210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]